Effects of a Functional COMT Polymorphism on Prefrontal Cognitive Function in Patients With 22q11.2 Deletion Syndrome
Authors:
- Carrie E. BeardenCBCarrie E. Bearden
- Abbas F. JawadAJAbbas F. Jawad
- David R. LynchDLDavid R. Lynch
- Set SokolSSSet Sokol
- Steven J. KanesSKSteven J. Kanes
- Donna M. McDonald-McGinnDMDonna M. McDonald-McGinn
- Sulagna C. SaittaSSSulagna C. Saitta
- Stacy E. HarrisSHStacy E. Harris
- Edward MossEMEdward Moss
- Paul P. WangPWPaul P. Wang
- Elaine ZackaiEZElaine Zackai
- Beverly S. EmanuelBEBeverly S. Emanuel
- 1 September 2004
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 161 (9) , 1700-1702
Abstract
The 22q11.2 deletion syndrome (DiGeorge/velocardiofacial syndrome) is associated with attentional problems and executive dysfunction, and is one of the highest known risk factors for schizophrenia. These behavioral manifestations of 22q11.2 deletion syndrome could result from haploinsufficiency of the catechol O-methyltransferase (COMT) gene, located within the 22q11 region. The goal of the present study was to examine COMT genotype as a predictor of prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Patients with confirmed 22q11.2 deletions (N=44) underwent neurocognitive testing following Val(158)Met genotyping (Met hemizygous: N=16; Val hemizygous: N=28). Analyses of covariance revealed that Met-hemizygous patients performed significantly better on a composite measure of executive function (comprising set-shifting, verbal fluency, attention, and working memory) than did Val-hemizygous patients. These data are consistent with those of previous studies in normal individuals, suggesting that a functional genetic polymorphism in the 22q11 region may influence prefrontal cognition in individuals with COMT haploinsufficiency.Keywords
This publication has 13 references indexed in Scilit:
- Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT‐1 in striatum of asymptomatic volunteers and patients with Parkinson's diseaseMovement Disorders, 2003
- The Neurocognitive Phenotype of the 22Q11.2 Deletion Syndrome: Selective Deficit in Visual-Spatial MemoryJournal of Clinical and Experimental Neuropsychology, 2001
- Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophreniaProceedings of the National Academy of Sciences, 2001
- Neuropsychological profile of children and adolescents with the 22q11.2 microdeletionGenetics in Medicine, 2001
- 22q11 deletion syndrome: a genetic subtype of schizophreniaBiological Psychiatry, 1999
- High Rates of Schizophrenia in Adults With Velo-Cardio-Facial SyndromeArchives of General Psychiatry, 1999
- Identification of Sequence Variants and Analysis of the Role of the Catechol-O-Methyl-Transferase Gene in Schizophrenia SusceptibilityBiological Psychiatry, 1998
- The 22q11.2 Deletion: Screening, Diagnostic Workup, and Outcome of Results; Report on 181 PatientsGenetic Testing, 1997
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1→q11.2Genomics, 1992